Tonix Pharmaceuticals Holding (TNXP) Total Liabilities (2023 - 2025)
Historic Total Liabilities for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to $21.3 million.
- Tonix Pharmaceuticals Holding's Total Liabilities rose 249.78% to $21.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.3 million, marking a year-over-year increase of 249.78%. This contributed to the annual value of $23.3 million for FY2024, which is 5231.75% down from last year.
- Tonix Pharmaceuticals Holding's Total Liabilities amounted to $21.3 million in Q3 2025, which was up 249.78% from $19.4 million recorded in Q2 2025.
- Tonix Pharmaceuticals Holding's 5-year Total Liabilities high stood at $48.9 million for Q4 2023, and its period low was $12.5 million during Q1 2025.
- In the last 3 years, Tonix Pharmaceuticals Holding's Total Liabilities had a median value of $20.8 million in 2024 and averaged $23.0 million.
- Per our database at Business Quant, Tonix Pharmaceuticals Holding's Total Liabilities surged by 9910.69% in 2024 and then tumbled by 5413.97% in 2025.
- Over the past 3 years, Tonix Pharmaceuticals Holding's Total Liabilities (Quarter) stood at $48.9 million in 2023, then tumbled by 52.32% to $23.3 million in 2024, then decreased by 8.72% to $21.3 million in 2025.
- Its Total Liabilities stands at $21.3 million for Q3 2025, versus $19.4 million for Q2 2025 and $12.5 million for Q1 2025.